Clinical Trial

Organ Preservation in Locally Advanced Rectal Cancer

Study acronym: PRONAR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2018 (before its estimated February 2022 completion). Its status may not reflect the trial's current state.
Summary
PRONAR trial aims to assess if treatment with organ preservation in stage II and III rectal cancer after a complete or almost complete response to neoadjuvant treatment is feasible and safe in our environment. The main objective of this project is to implement the organ preservation strategy in the treatment of rectal cancer in our environment within a clinical study that allows the analysis of its results in terms of survival. The secondary objective is to assess local relapse, distant relapse and quality of life.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2017-02-24; most recent amendment 2018-09-25.
Status change: Not Yet Recruiting → Recruiting 2017-03-10
Trial Details
NCT Number NCT03064646
Lead Sponsor Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Collaborators: Hospital General Universitario Elche
Conditions LOCALLY ADVANCED RECTAL CANCER
Enrollment 30 participants
Start Date 2017-03-10
Primary Completion 2022-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2018-09-27